Skip to main content

Table 1 Overview of group size (n), age, weight, injected activity, injected mass, and molar activity for [11C]PiB and [18F]THK-5317 PET imaging

From: Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labeling

[11C]PiB

n

Age (months)

Weight (g)

Inj. Activity (MBq)

Inj. Mass (nmol/kg)

Molar activity (GBq/μmol)

Female APP/hTau

3

6.7 ± 0.3

257.7 ± 32.7

23.6 ± 6.1

3.2 ± 1.2

29.9 ± 5.0

Male APP/hTau

3

7.1 ± 0.1

493.0 ± 51.4

26.3 ± 0.7

6.1 ± 4.1

16.2 ± 16.8

Female APP/hTau

8

12.1 ± 0.6

334.5 ± 30.8

14.8 ± 2.2

0.4 ± 0.1

115.1 ± 12.9

Male APP/hTau

10

12.4 ± 0.7

540.6 ± 47.6

16.7 ± 3.3

0.3 ± 0.0

109.3 ± 22.7

Female APP/hTau

8

20.5 ± 0.5

347.0 ± 48.8

21.1 ± 1.1

0.6 ± 0.2

21.1 ± 1.1

Male APP/hTau

10

20.6 ± 0.3

606.9 ± 43.8

31.0 ± 16.8

0.5 ± 0.3

31.0 ± 16.8

[18F]THK-5317

n

Age (months)

Weight (g)

Inj. Activity (MBq)

Inj. Mass (nmol/kg)

Molar activity (GBq/μmol)

Female ntg

6

7.0 ± 0.2

273.3 ± 17.6

19.2 ± 5.2

1.5 ± 0.6

52.5 ± 16.7

Female APP/hTau

7

7.0 ± 0.4

263.4 ± 21.2

17.8 ± 3.1

1.4 ± 1.7

149.9 ± 122.8

Male ntg

6

7.1 ± 0.1

491.2 ± 57.5

16.2 ± 3.8

0.7 ± 0.1

53.7 ± 15.2

Male APP/hTau

7

7.1 ± 0.3

485.6 ± 65.8

17.4 ± 3.8

0.3 ± 0.1

182.0 ± 118.6

Female ntg

6

12.8 ± 0.5

300.3 ± 38.0

15.0 ± 1.5

0.9 ± 0.5

71.3 ± 45.1

female APP/hTau

11

12.5 ± 0.5

319.7 ± 28.7

11.6 ± 4.3

0.7 ± 0.6

83.6 ± 66.3

Male ntg

2

13.4 ± 0.4

632.5 ± 0.7

8.8 ± 3.9

0.4 ± 0.5

194.8 ± 257.6

male APP/hTau

10

12.9 ± 0.4

520.3 ± 53.4

15.9 ± 4.3

0.4 ± 0.3

135.4 ± 99.1

Female ntg

4

20.7 ± 0.4

354.0 ± 82.9

18.5 ± 2.6

0.9 ± 1.0

103.1 ± 46.1

Female APP/hTau

6

20.7 ± 0.6

342.8 ± 52.1

16.2 ± 1.2

0.2 ± 0.1

388.9 ± 236.8

Male ntg

4

21.0 ± 0.3

538.3 ± 54.4

16.3 ± 2.5

0.6 ± 0.5

88.0 ± 70.8

Male APP/hTau

10

20.9 ± 0.3

594.5 ± 48.9

15.2 ± 2.6

0.2 ± 0.3

181.4 ± 112.6